These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32661654)

  • 1. Comparison of covariate selection methods with correlated covariates: prior information versus data information, or a mixture of both?
    Chasseloup E; Yngman G; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):485-492. PubMed ID: 32661654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model.
    Ribbing J; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Apr; 31(2):109-34. PubMed ID: 15379381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operating characteristics of stepwise covariate selection in pharmacometric modeling.
    Ahamadi M; Largajolli A; Diderichsen PM; de Greef R; Kerbusch T; Witjes H; Chawla A; Davis CB; Gheyas F
    J Pharmacokinet Pharmacodyn; 2019 Jun; 46(3):273-285. PubMed ID: 31020450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
    Ribbing J; Nyberg J; Caster O; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2007 Aug; 34(4):485-517. PubMed ID: 17516152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Modified Hybrid Wald's Approximation Method for Efficient Covariate Selection in Population Pharmacokinetic Analysis.
    Zou Y; Tang F; Ng CM
    AAPS J; 2021 Mar; 23(2):37. PubMed ID: 33660056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reduction in between subject variability is not mandatory for selecting a new covariate.
    Lagishetty CV; Vajjah P; Duffull SB
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):383-92. PubMed ID: 22767340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational characteristics of full random effects modelling ('frem') compared to stepwise covariate modelling ('scm').
    Amann LF; Wicha SG
    J Pharmacokinet Pharmacodyn; 2023 Aug; 50(4):315-326. PubMed ID: 37083930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
    Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full covariate modelling approach in population pharmacokinetics: understanding the underlying hypothesis tests and implications of multiplicity.
    Xu XS; Yuan M; Zhu H; Yang Y; Wang H; Zhou H; Xu J; Zhang L; Pinheiro J
    Br J Clin Pharmacol; 2018 Jul; 84(7):1525-1534. PubMed ID: 29522646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools.
    Goulooze SC; Krekels EHJ; Hankemeier T; Knibbe CAJ
    AAPS J; 2018 Dec; 21(1):11. PubMed ID: 30565031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An introduction to the full random effects model.
    Yngman G; Bjugård Nyberg H; Nyberg J; Jonsson EN; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2022 Feb; 11(2):149-160. PubMed ID: 34984855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the unified model based multifactor dimensionality reduction methods for identifying gene-gene interactions associated with the survival phenotype.
    Lee JW; Lee S
    BioData Min; 2021 Mar; 14(1):17. PubMed ID: 33648540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of different tests based on observations for external model evaluation of population analyses.
    Brendel K; Comets E; Laffont C; Mentré F
    J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):49-65. PubMed ID: 20033477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach.
    Ayral G; Si Abdallah JF; Magnard C; Chauvin J
    CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):318-329. PubMed ID: 33755345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.
    Wählby U; Jonsson EN; Karlsson MO
    AAPS PharmSci; 2002; 4(4):E27. PubMed ID: 12645999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of covariate selection in controlling for selection bias in observational studies.
    Steiner PM; Cook TD; Shadish WR; Clark MH
    Psychol Methods; 2010 Sep; 15(3):250-67. PubMed ID: 20822251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine.
    Chan Kwong AHP; Calvier EAM; Fabre D; Gattacceca F; Khier S
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):431-446. PubMed ID: 32535847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation of correlated continuous and categorical variables using a single multivariate distribution.
    Tannenbaum SJ; Holford NH; Lee H; Peck CC; Mould DR
    J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6):773-94. PubMed ID: 17053984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
    Bonate PL
    Pharm Stat; 2017 Jan; 16(1):45-54. PubMed ID: 27580760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of covariate adjustment for adaptive multi-arm designs.
    Lee KM; Robertson DS; Jaki T; Emsley R
    Stat Methods Med Res; 2022 Nov; 31(11):2104-2121. PubMed ID: 35876412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.